Concepts (272)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Microglia | 36 | 2026 | 254 | 10.900 |
Why?
|
| Central Nervous System | 12 | 2025 | 200 | 5.430 |
Why?
|
| Neuronal Plasticity | 10 | 2026 | 154 | 3.900 |
Why?
|
| Synapses | 11 | 2026 | 195 | 3.210 |
Why?
|
| Neurons | 16 | 2026 | 935 | 1.940 |
Why?
|
| Astrocytes | 8 | 2026 | 123 | 1.470 |
Why?
|
| Neuroglia | 8 | 2026 | 81 | 1.450 |
Why?
|
| Neurodegenerative Diseases | 5 | 2025 | 152 | 1.450 |
Why?
|
| Multiple Sclerosis | 8 | 2025 | 227 | 1.450 |
Why?
|
| Neurogenesis | 4 | 2026 | 64 | 1.400 |
Why?
|
| Cytokines | 6 | 2026 | 964 | 1.360 |
Why?
|
| Animals | 52 | 2026 | 21459 | 1.300 |
Why?
|
| Phagocytosis | 6 | 2024 | 257 | 1.160 |
Why?
|
| CX3C Chemokine Receptor 1 | 3 | 2025 | 12 | 0.990 |
Why?
|
| Mice | 30 | 2026 | 11173 | 0.940 |
Why?
|
| Rett Syndrome | 2 | 2016 | 8 | 0.940 |
Why?
|
| Methyl-CpG-Binding Protein 2 | 2 | 2016 | 18 | 0.920 |
Why?
|
| Brain | 11 | 2026 | 1625 | 0.900 |
Why?
|
| Macrophages | 8 | 2025 | 1041 | 0.900 |
Why?
|
| Wnt Signaling Pathway | 1 | 2025 | 87 | 0.860 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 3 | 2025 | 60 | 0.860 |
Why?
|
| Vibrissae | 2 | 2025 | 7 | 0.830 |
Why?
|
| Chemokine CX3CL1 | 2 | 2025 | 7 | 0.830 |
Why?
|
| Lipofuscin | 1 | 2023 | 5 | 0.810 |
Why?
|
| Phagocytes | 2 | 2014 | 52 | 0.810 |
Why?
|
| Nucleic Acids | 1 | 2024 | 67 | 0.790 |
Why?
|
| Integrases | 1 | 2023 | 41 | 0.780 |
Why?
|
| Mice, Inbred C57BL | 15 | 2026 | 3500 | 0.730 |
Why?
|
| Interferon Regulatory Factors | 1 | 2022 | 43 | 0.730 |
Why?
|
| Thalamus | 2 | 2019 | 78 | 0.710 |
Why?
|
| Seizures | 1 | 2022 | 141 | 0.680 |
Why?
|
| Interleukin-6 | 2 | 2022 | 323 | 0.670 |
Why?
|
| Synaptic Transmission | 2 | 2023 | 151 | 0.670 |
Why?
|
| Cerebral Cortex | 3 | 2020 | 270 | 0.660 |
Why?
|
| Immunity, Cellular | 1 | 2021 | 170 | 0.650 |
Why?
|
| Immunity, Innate | 3 | 2024 | 829 | 0.630 |
Why?
|
| Complement C3 | 2 | 2019 | 61 | 0.630 |
Why?
|
| Cell Communication | 2 | 2025 | 135 | 0.620 |
Why?
|
| Ranvier's Nodes | 4 | 2011 | 4 | 0.610 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2022 | 604 | 0.600 |
Why?
|
| ADAM10 Protein | 1 | 2019 | 11 | 0.600 |
Why?
|
| Sensorimotor Cortex | 1 | 2019 | 4 | 0.600 |
Why?
|
| Touch | 1 | 2019 | 27 | 0.590 |
Why?
|
| Schizophrenia | 1 | 2021 | 275 | 0.580 |
Why?
|
| Amyloid Precursor Protein Secretases | 1 | 2019 | 76 | 0.580 |
Why?
|
| Axons | 3 | 2009 | 124 | 0.580 |
Why?
|
| Autism Spectrum Disorder | 1 | 2021 | 181 | 0.550 |
Why?
|
| Signal Transduction | 4 | 2026 | 3162 | 0.550 |
Why?
|
| Humans | 34 | 2026 | 65645 | 0.530 |
Why?
|
| Nervous System | 1 | 2016 | 71 | 0.460 |
Why?
|
| Myelin Sheath | 3 | 2025 | 39 | 0.460 |
Why?
|
| Oligodendroglia | 7 | 2026 | 40 | 0.440 |
Why?
|
| Organogenesis | 1 | 2015 | 40 | 0.440 |
Why?
|
| Macrophages, Peritoneal | 1 | 2015 | 75 | 0.440 |
Why?
|
| Membrane Proteins | 2 | 2025 | 925 | 0.420 |
Why?
|
| CpG Islands | 1 | 2015 | 219 | 0.410 |
Why?
|
| Alzheimer Disease | 3 | 2025 | 768 | 0.410 |
Why?
|
| Immune System | 2 | 2015 | 132 | 0.390 |
Why?
|
| Macrophage-1 Antigen | 1 | 2012 | 29 | 0.360 |
Why?
|
| Mice, Knockout | 6 | 2026 | 2168 | 0.350 |
Why?
|
| Female | 17 | 2026 | 34309 | 0.350 |
Why?
|
| Epigenesis, Genetic | 1 | 2015 | 408 | 0.350 |
Why?
|
| Infarction, Middle Cerebral Artery | 2 | 2009 | 98 | 0.340 |
Why?
|
| Cytoskeleton | 3 | 2020 | 141 | 0.340 |
Why?
|
| Induced Pluripotent Stem Cells | 2 | 2024 | 160 | 0.340 |
Why?
|
| Cellular Senescence | 2 | 2025 | 121 | 0.340 |
Why?
|
| Aging | 3 | 2025 | 775 | 0.340 |
Why?
|
| Microscopy, Confocal | 3 | 2023 | 240 | 0.330 |
Why?
|
| Disease Models, Animal | 6 | 2026 | 2326 | 0.320 |
Why?
|
| Transcriptome | 6 | 2025 | 405 | 0.300 |
Why?
|
| Male | 17 | 2025 | 31292 | 0.300 |
Why?
|
| Plaque, Amyloid | 2 | 2025 | 42 | 0.290 |
Why?
|
| Nerve Growth Factors | 2 | 2009 | 28 | 0.280 |
Why?
|
| Cell Adhesion Molecules | 2 | 2009 | 95 | 0.270 |
Why?
|
| Amyotrophic Lateral Sclerosis | 2 | 2024 | 517 | 0.260 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2006 | 30 | 0.240 |
Why?
|
| Cell Lineage | 2 | 2019 | 282 | 0.240 |
Why?
|
| Single-Cell Analysis | 3 | 2025 | 118 | 0.240 |
Why?
|
| Rats | 6 | 2019 | 1996 | 0.240 |
Why?
|
| Th17 Cells | 1 | 2026 | 65 | 0.240 |
Why?
|
| Encephalitis | 1 | 2026 | 39 | 0.240 |
Why?
|
| Neuroprotection | 1 | 2025 | 3 | 0.230 |
Why?
|
| Retinal Ganglion Cells | 2 | 2019 | 34 | 0.230 |
Why?
|
| Streptococcal Infections | 1 | 2026 | 87 | 0.230 |
Why?
|
| Inflammation | 4 | 2025 | 1195 | 0.230 |
Why?
|
| Retina | 3 | 2024 | 135 | 0.230 |
Why?
|
| Remyelination | 1 | 2025 | 3 | 0.220 |
Why?
|
| Neural Inhibition | 1 | 2025 | 30 | 0.220 |
Why?
|
| Body Patterning | 2 | 2016 | 94 | 0.220 |
Why?
|
| Cell Death | 3 | 2025 | 289 | 0.220 |
Why?
|
| Skull | 2 | 2023 | 52 | 0.220 |
Why?
|
| Corpus Striatum | 1 | 2025 | 98 | 0.220 |
Why?
|
| Mice, Transgenic | 3 | 2025 | 1291 | 0.220 |
Why?
|
| GABAergic Neurons | 1 | 2025 | 38 | 0.220 |
Why?
|
| Binge Drinking | 1 | 2025 | 39 | 0.210 |
Why?
|
| Endothelial Cells | 1 | 2026 | 215 | 0.210 |
Why?
|
| Callithrix | 2 | 2025 | 21 | 0.210 |
Why?
|
| Vesicular Transport Proteins | 1 | 2025 | 117 | 0.210 |
Why?
|
| Prefrontal Cortex | 1 | 2025 | 128 | 0.210 |
Why?
|
| Optic Nerve | 1 | 2004 | 29 | 0.210 |
Why?
|
| Membrane Microdomains | 1 | 2004 | 51 | 0.200 |
Why?
|
| Cell Membrane | 1 | 2006 | 506 | 0.200 |
Why?
|
| Brain Mapping | 1 | 2025 | 240 | 0.200 |
Why?
|
| Choroid Plexus | 1 | 2023 | 15 | 0.190 |
Why?
|
| CD47 Antigen | 1 | 2022 | 6 | 0.190 |
Why?
|
| Syk Kinase | 1 | 2022 | 5 | 0.190 |
Why?
|
| Hydrocephalus | 1 | 2023 | 41 | 0.180 |
Why?
|
| Interleukin-18 Receptor beta Subunit | 1 | 2022 | 2 | 0.180 |
Why?
|
| Cell Count | 2 | 2019 | 128 | 0.180 |
Why?
|
| Circadian Rhythm | 1 | 2025 | 363 | 0.180 |
Why?
|
| Olfactory Bulb | 1 | 2022 | 19 | 0.180 |
Why?
|
| Olfactory Receptor Neurons | 1 | 2022 | 17 | 0.180 |
Why?
|
| Receptors, Immunologic | 1 | 2022 | 179 | 0.180 |
Why?
|
| Polyadenylation | 1 | 2022 | 51 | 0.180 |
Why?
|
| mRNA Cleavage and Polyadenylation Factors | 1 | 2022 | 72 | 0.170 |
Why?
|
| Ethanol | 2 | 2025 | 333 | 0.170 |
Why?
|
| Mitochondria | 1 | 2025 | 413 | 0.170 |
Why?
|
| STAT3 Transcription Factor | 1 | 2021 | 70 | 0.170 |
Why?
|
| Brain Injuries, Traumatic | 1 | 2023 | 96 | 0.170 |
Why?
|
| Gene Transfer Techniques | 1 | 2023 | 325 | 0.170 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2021 | 50 | 0.170 |
Why?
|
| Receptors, CCR2 | 1 | 2020 | 13 | 0.160 |
Why?
|
| Somatosensory Cortex | 1 | 2020 | 20 | 0.160 |
Why?
|
| Capillaries | 1 | 2020 | 35 | 0.160 |
Why?
|
| Lymphocytes | 1 | 2021 | 209 | 0.160 |
Why?
|
| Autophagy | 1 | 2023 | 239 | 0.160 |
Why?
|
| Receptors, CCR5 | 1 | 2020 | 59 | 0.160 |
Why?
|
| Receptors, Complement 3b | 1 | 2019 | 12 | 0.160 |
Why?
|
| Age Factors | 2 | 2021 | 1592 | 0.160 |
Why?
|
| Gliosis | 1 | 2019 | 27 | 0.160 |
Why?
|
| Microfilament Proteins | 1 | 2020 | 115 | 0.150 |
Why?
|
| Oligodendrocyte Precursor Cells | 1 | 2019 | 1 | 0.150 |
Why?
|
| Microfluidic Analytical Techniques | 1 | 2019 | 28 | 0.150 |
Why?
|
| Cell Line, Tumor | 2 | 2020 | 1573 | 0.140 |
Why?
|
| Models, Neurological | 2 | 2018 | 83 | 0.140 |
Why?
|
| Glioblastoma | 1 | 2020 | 161 | 0.140 |
Why?
|
| Complement System Proteins | 1 | 2019 | 110 | 0.140 |
Why?
|
| Transforming Growth Factor beta | 1 | 2019 | 181 | 0.140 |
Why?
|
| Tremor | 1 | 2018 | 25 | 0.130 |
Why?
|
| Cells, Cultured | 4 | 2019 | 2189 | 0.130 |
Why?
|
| Deep Brain Stimulation | 1 | 2018 | 68 | 0.130 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2015 | 663 | 0.130 |
Why?
|
| Nerve Tissue Proteins | 3 | 2009 | 428 | 0.120 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2019 | 624 | 0.120 |
Why?
|
| Endocytosis | 1 | 2016 | 152 | 0.110 |
Why?
|
| Cell Proliferation | 2 | 2020 | 1042 | 0.110 |
Why?
|
| Antibodies | 2 | 2015 | 188 | 0.110 |
Why?
|
| Central Nervous System Diseases | 1 | 2015 | 57 | 0.110 |
Why?
|
| Nerve Net | 1 | 2016 | 103 | 0.110 |
Why?
|
| Inflammation Mediators | 2 | 2020 | 179 | 0.110 |
Why?
|
| Craniotomy | 1 | 2014 | 20 | 0.110 |
Why?
|
| Myeloid Cells | 1 | 2015 | 98 | 0.110 |
Why?
|
| Pregnancy | 1 | 2021 | 2393 | 0.100 |
Why?
|
| Blood-Brain Barrier | 2 | 2026 | 89 | 0.100 |
Why?
|
| Transcription Factors | 1 | 2022 | 1559 | 0.100 |
Why?
|
| Cell Differentiation | 2 | 2019 | 1389 | 0.100 |
Why?
|
| Stroke | 1 | 2023 | 1221 | 0.100 |
Why?
|
| Cell Survival | 1 | 2015 | 588 | 0.100 |
Why?
|
| Behavior, Animal | 1 | 2015 | 234 | 0.100 |
Why?
|
| RNA, Messenger | 1 | 2019 | 1580 | 0.100 |
Why?
|
| Gene Expression Regulation | 1 | 2019 | 1633 | 0.090 |
Why?
|
| Gangliosides | 1 | 2011 | 19 | 0.090 |
Why?
|
| Polyneuropathies | 1 | 2011 | 13 | 0.090 |
Why?
|
| Diagnostic Imaging | 1 | 2014 | 273 | 0.090 |
Why?
|
| Analysis of Variance | 2 | 2009 | 606 | 0.090 |
Why?
|
| Spectrin | 2 | 2011 | 8 | 0.080 |
Why?
|
| Middle Aged | 4 | 2021 | 18439 | 0.080 |
Why?
|
| Calpain | 1 | 2009 | 8 | 0.080 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 2009 | 23 | 0.080 |
Why?
|
| Aged, 80 and over | 1 | 2019 | 5656 | 0.070 |
Why?
|
| Calcium-Binding Proteins | 1 | 2009 | 95 | 0.070 |
Why?
|
| Neuroprotective Agents | 1 | 2009 | 80 | 0.070 |
Why?
|
| Brain Infarction | 1 | 2009 | 21 | 0.070 |
Why?
|
| Embryo, Mammalian | 1 | 2009 | 158 | 0.070 |
Why?
|
| Hypoxia | 1 | 2009 | 121 | 0.070 |
Why?
|
| Brain Chemistry | 2 | 2009 | 76 | 0.070 |
Why?
|
| Green Fluorescent Proteins | 1 | 2009 | 372 | 0.070 |
Why?
|
| Transfection | 1 | 2009 | 700 | 0.070 |
Why?
|
| Receptors, Interleukin-17 | 1 | 2026 | 4 | 0.060 |
Why?
|
| Neural Cell Adhesion Molecules | 1 | 2006 | 13 | 0.060 |
Why?
|
| Glucose | 1 | 2009 | 478 | 0.060 |
Why?
|
| Ankyrins | 1 | 2006 | 3 | 0.060 |
Why?
|
| Gap Junctions | 1 | 2006 | 18 | 0.060 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2026 | 74 | 0.060 |
Why?
|
| Aged | 2 | 2019 | 15089 | 0.060 |
Why?
|
| Chemokines | 1 | 2026 | 99 | 0.060 |
Why?
|
| Interleukin-17 | 1 | 2026 | 101 | 0.060 |
Why?
|
| CD28 Antigens | 1 | 2025 | 62 | 0.060 |
Why?
|
| Optogenetics | 1 | 2025 | 31 | 0.060 |
Why?
|
| Chemokine CCL11 | 1 | 2025 | 4 | 0.060 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2025 | 15 | 0.060 |
Why?
|
| Demyelinating Diseases | 1 | 2025 | 15 | 0.060 |
Why?
|
| DNA, Mitochondrial | 1 | 2025 | 89 | 0.050 |
Why?
|
| Models, Biological | 1 | 2010 | 1193 | 0.050 |
Why?
|
| Mice, Neurologic Mutants | 1 | 2004 | 13 | 0.050 |
Why?
|
| Subcellular Fractions | 1 | 2004 | 67 | 0.050 |
Why?
|
| Detergents | 1 | 2004 | 35 | 0.050 |
Why?
|
| Atrophy | 1 | 2024 | 87 | 0.050 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2025 | 2262 | 0.050 |
Why?
|
| Profilins | 1 | 2024 | 44 | 0.050 |
Why?
|
| Trans-Activators | 1 | 2025 | 321 | 0.050 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2025 | 344 | 0.050 |
Why?
|
| Solubility | 1 | 2004 | 193 | 0.050 |
Why?
|
| Protein Isoforms | 1 | 2004 | 201 | 0.050 |
Why?
|
| Amyloid beta-Peptides | 1 | 2025 | 322 | 0.050 |
Why?
|
| Intravital Microscopy | 1 | 2023 | 13 | 0.050 |
Why?
|
| Models, Animal | 1 | 2024 | 242 | 0.050 |
Why?
|
| Beclin-1 | 1 | 2023 | 22 | 0.050 |
Why?
|
| Coloring Agents | 1 | 2023 | 51 | 0.050 |
Why?
|
| Proteomics | 1 | 2025 | 299 | 0.050 |
Why?
|
| Protein Transport | 1 | 2004 | 405 | 0.050 |
Why?
|
| Head | 1 | 2023 | 57 | 0.050 |
Why?
|
| Antigens, Differentiation | 1 | 2022 | 144 | 0.050 |
Why?
|
| Sirolimus | 1 | 2023 | 93 | 0.050 |
Why?
|
| Odorants | 1 | 2022 | 19 | 0.050 |
Why?
|
| Smell | 1 | 2022 | 29 | 0.040 |
Why?
|
| Complement C1q | 1 | 2021 | 17 | 0.040 |
Why?
|
| 3' Untranslated Regions | 1 | 2022 | 96 | 0.040 |
Why?
|
| Gene Expression Profiling | 1 | 2025 | 797 | 0.040 |
Why?
|
| Disease Progression | 1 | 2025 | 1227 | 0.040 |
Why?
|
| Oxygen | 1 | 2023 | 321 | 0.040 |
Why?
|
| Sulfoxides | 1 | 2020 | 16 | 0.040 |
Why?
|
| CCR5 Receptor Antagonists | 1 | 2020 | 17 | 0.040 |
Why?
|
| Motor Neurons | 1 | 2022 | 219 | 0.040 |
Why?
|
| Mammals | 1 | 2022 | 222 | 0.040 |
Why?
|
| Imidazoles | 1 | 2020 | 82 | 0.040 |
Why?
|
| White Matter | 1 | 2021 | 128 | 0.040 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2020 | 233 | 0.040 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2020 | 211 | 0.040 |
Why?
|
| In Vitro Techniques | 1 | 2020 | 491 | 0.040 |
Why?
|
| RNA, Small Nuclear | 1 | 2019 | 25 | 0.040 |
Why?
|
| Autopsy | 1 | 2019 | 56 | 0.040 |
Why?
|
| Cryopreservation | 1 | 2019 | 30 | 0.040 |
Why?
|
| Lipopolysaccharides | 1 | 2022 | 625 | 0.040 |
Why?
|
| Blotting, Western | 1 | 2020 | 611 | 0.040 |
Why?
|
| Macrophage Colony-Stimulating Factor | 1 | 2019 | 33 | 0.040 |
Why?
|
| Animals, Newborn | 1 | 2019 | 241 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 1 | 2020 | 869 | 0.040 |
Why?
|
| RNA | 1 | 2022 | 427 | 0.040 |
Why?
|
| Cell Movement | 1 | 2020 | 482 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2020 | 898 | 0.030 |
Why?
|
| Electrodes, Implanted | 1 | 2018 | 38 | 0.030 |
Why?
|
| Homeodomain Proteins | 1 | 2019 | 277 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2019 | 858 | 0.030 |
Why?
|
| Brain Neoplasms | 1 | 2020 | 319 | 0.030 |
Why?
|
| Mutation | 1 | 2024 | 2670 | 0.030 |
Why?
|
| Implants, Experimental | 1 | 2014 | 5 | 0.030 |
Why?
|
| Wakefulness | 1 | 2014 | 44 | 0.030 |
Why?
|
| Electroencephalography | 1 | 2014 | 156 | 0.030 |
Why?
|
| Equipment Design | 1 | 2014 | 373 | 0.020 |
Why?
|
| Time Factors | 2 | 2011 | 3777 | 0.020 |
Why?
|
| Choline O-Acetyltransferase | 1 | 2011 | 2 | 0.020 |
Why?
|
| Neural Conduction | 1 | 2011 | 32 | 0.020 |
Why?
|
| Ganglia, Spinal | 1 | 2011 | 30 | 0.020 |
Why?
|
| Injections, Subcutaneous | 1 | 2011 | 70 | 0.020 |
Why?
|
| Sciatic Nerve | 1 | 2011 | 31 | 0.020 |
Why?
|
| Gangliosidosis, GM1 | 1 | 2011 | 26 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2011 | 213 | 0.020 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2011 | 139 | 0.020 |
Why?
|
| Rabbits | 1 | 2011 | 342 | 0.020 |
Why?
|
| Spinal Cord | 1 | 2011 | 210 | 0.020 |
Why?
|
| Acute Disease | 1 | 2011 | 663 | 0.020 |
Why?
|
| Tetrazolium Salts | 1 | 2009 | 14 | 0.020 |
Why?
|
| Fluoresceins | 1 | 2009 | 31 | 0.020 |
Why?
|
| Organic Chemicals | 1 | 2009 | 27 | 0.020 |
Why?
|
| Nerve Degeneration | 1 | 2009 | 68 | 0.020 |
Why?
|
| Staining and Labeling | 1 | 2009 | 127 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2018 | 6948 | 0.010 |
Why?
|
| Nuclear Proteins | 1 | 2009 | 792 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2009 | 1567 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2009 | 1226 | 0.010 |
Why?
|
| Adult | 1 | 2019 | 17511 | 0.010 |
Why?
|